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AbstrAct
Objective
To determine associations between important pre-
arrest and intra-arrest prognostic factors and survival 
after in-hospital cardiac arrest.
Design
Systematic review and meta-analysis.
Data sOurces
Medline, PubMed, Embase, Scopus, Web of 
Science, and the Cochrane Database of Systematic 
Reviews from inception to 4 February 2019. Primary, 
unpublished data from the United Kingdom National 
Cardiac Arrest Audit database.
stuDy selectiOn criteria
English language studies that investigated pre-arrest 
and intra-arrest prognostic factors and survival after 
in-hospital cardiac arrest.
Data extractiOn
PROGRESS (prognosis research strategy group) 
recommendations and the CHARMS (critical 
appraisal and data extraction for systematic 
reviews of prediction modelling studies) checklist 
were followed. Risk of bias was assessed by using 
the QUIPS tool (quality in prognosis studies). The 
primary analysis pooled associations only if they 
were adjusted for relevant confounders. The GRADE 
approach (grading of recommendations assessment, 
development, and evaluation) was used to rate 
certainty in the evidence.
results
The primary analysis included 23 cohort studies. Of 
the pre-arrest factors, male sex (odds ratio 0.84, 95% 
confidence interval 0.73 to 0.95, moderate certainty), 
age 60 or older (0.50, 0.40 to 0.62, low certainty), 
active malignancy (0.57, 0.45 to 0.71, high certainty), 
and history of chronic kidney disease (0.56, 0.40 to 
0.78, high certainty) were associated with reduced 
odds of survival after in-hospital cardiac arrest. Of 
the intra-arrest factors, witnessed arrest (2.71, 2.17 
to 3.38, high certainty), monitored arrest (2.23, 
1.41 to 3.52, high certainty), arrest during daytime 
hours (1.41, 1.20 to 1.66, high certainty), and initial 
shockable rhythm (5.28, 3.78 to 7.39, high certainty) 
were associated with increased odds of survival. 
Intubation during arrest (0.54, 0.42 to 0.70, moderate 
certainty) and duration of resuscitation of at least 
15 minutes (0.12, 0.07 to 0.19, high certainty) were 
associated with reduced odds of survival.
cOnclusiOn
Moderate to high certainty evidence was found for 
associations of pre-arrest and intra-arrest prognostic 
factors with survival after in-hospital cardiac arrest.
systematic review registratiOn
PROSPERO CRD42018104795
Introduction
Cardiac arrest refers to cessation of mechanical heart 
function and effective blood circulation, and is typically 
considered as either out-of-hospital cardiac arrest or 
in-hospital cardiac arrest.1 2 Although evidence from 
out-of-hospital cardiac arrest is often extrapolated to in-
hospital cardiac arrest, the epidemiology is different, and 
the determinants of success might differ accordingly.1 3 
In comparison to out-of-hospital cardiac arrest, data 
on incidence and survival after in-hospital cardiac 
arrest are limited. Most studies report an incidence 
of one to six events per 1000 hospital admissions.4 5 
Survival to discharge ranges between 12% and 25%, 
with increased survival recently reported.1 6 7 One year 
outcomes are similar, with only modest increases over 
the past decade.8
Prognostic factors associated with survival after 
in-hospital cardiac arrest are an important focus 
of ongoing research.2 Patients admitted to hospital 
have increasingly complex conditions and present 
unique challenges when managing in-hospital cardiac 
arrest. Clinicians have to rapidly process many factors 
related to preadmission status (including age, sex, 
comorbidities) and factors related to the arrest itself 
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WhAt Is AlreAdy knoWn on thIs topIc
In-hospital cardiac arrest is associated with low survival rates
Much of our clinical understanding of in-hospital cardiac arrest is deduced from 
the extensive literature on out-of-hospital cardiac arrest
Understanding pre-arrest and intra-arrest prognostic factors associated with 
survival after in-hospital cardiac arrest is an important area of research
WhAt thIs study Adds
Of the pre-arrest factors, increasing age, male sex, active malignancy, and 
chronic kidney disease were associated with reduced survival after in-hospital 
cardiac arrest
Of the intra-arrest factors, witnessed arrest, monitored setting, arrest during 
daytime hours, and shockable rhythm were associated with increased survival 
after in-hospital cardiac arrest; increased duration of resuscitation and tracheal 
intubation were associated with reduced survival
The study identified important prognostic factors associated with outcome 
after in-hospital cardiac arrest, which could be used when discussing expected 
prognosis and advanced directives with patients
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(whether the arrest was witnessed or monitored, 
initial rhythm) to determine the effectiveness of 
ongoing cardiopulmonary resuscitation. Additionally, 
clinicians need to discuss expected prognosis after 
in-hospital cardiac arrest with patients at the time of 
hospital admission to inform care plans, and whether 
to include cardiopulmonary resuscitation in the event 
of cardiac arrest.3 9 10 Patient understanding of survival 
after in-hospital cardiac arrest is poor, and is often 
influenced by popular media where unrealistic rates 
of survival to discharge approach 67%.11 Furthermore, 
when discussing inclusion of cardiopulmonary resus-
citation in goals of care, clinicians rarely mention 
prognostic factors and likelihood of survival after in-
hospital cardiac arrest.12
A greater understanding of the factors associated 
with successful resuscitation of patients with in-
hospital cardiac arrest is needed. This information will 
help in developing a predictive model used in shared 
decision making with patients and families, and clinical 
decision making at the time of in-hospital cardiac 
arrest and after return of spontaneous circulation. 
Therefore, we conducted a systematic review and 
meta-analysis to summarise the association between 
pre-arrest and intra-arrest factors and survival after in-
hospital cardiac arrest.
Methods
We conducted this systematic review and meta-
analysis according to PROGRESS (prognosis research 
strategy group) recommendations,13-16 and recent 
guidelines for systematic reviews and meta-analyses of 
prognostic factors.17 The CHARMS (critical appraisal 
and data extraction for systematic reviews of prediction 
modelling studies) checklist18 was used to define and 
frame the study. We registered the review protocol with 
the PROSPERO registry (CRD42018104795).
Data sources and searches
We searched Medline, PubMed, Embase, Scopus, Web 
of Science, and the Cochrane Database of Systematic 
Reviews from inception to 4 February 2019. An ex-
perienced health sciences librarian assisted in 
developing the search strategy (supplemental fig 1), 
which was conducted using the terms “cardiac arrest,” 
combined with terms related to prognosis research, 
as recommended.17 We used the Science Citation 
Index to retrieve reports that cited the relevant articles 
identified from our search, and then entered them into 
PubMed and conducted further surveillance searches 
using the “Related Articles” feature.19
study selection
We included all English language full text articles that 
described retrospective and prospective observational 
studies, randomised controlled trials, and quasi 
randomised controlled trials. Inclusion criteria for 
studies were based on existing standards for research 
among patients with in-hospital cardiac arrest1 2: 
enrolled mostly (≥80%) adult patients (≥16 years) 
with in-hospital cardiac arrest; conducted in the 
emergency department, hospital wards, or intensive 
care unit; and evaluated mortality as an outcome of 
interest (in-hospital, 28 day, or 30 day mortality). 
We excluded studies that evaluated mortality over 
longer or unspecified time periods; case reports and 
case series; studies that included only patients who 
received a particular treatment after cardiac arrest 
(such as therapeutic hypothermia or extracorporeal 
life support); studies that included patients with 
out-of-hospital cardiac arrest; and studies that 
failed to provide model adjusted or unadjusted 
odds ratios with confidence intervals, or counts for 
calculating unadjusted odds ratios. We contacted the 
corresponding authors to obtain further information 
when these values could not be obtained from the 
reported data.
We screened studies using Covidence software 
(Melbourne, Australia); titles were imported into 
Covidence directly from the search databases and 
duplicates removed. Two reviewers (SMF and AT) 
independently screened the titles and abstracts of 
all identified citations. Disagreement was resolved 
by discussion; no third party adjudication proved 
necessary. The same two reviewers independently 
assessed full texts of the selected articles after 
screening and again resolved any disagreement by 
discussion.
Data extraction and quality assessment
Two investigators (SMF and AT) abstracted the follow-
ing variables: author information, year of publication, 
study design, study dates, definition of start points, 
eligibility criteria, number of patients included, and 
incidence of mortality. We used a predesigned data 
extraction sheet (supplemental table 2) to minimise 
transcription errors. Subsequently, for each prognostic 
factor, two investigators (SMF and AT) independently 
collected unadjusted or adjusted odds ratios for 
survival in each study, if available. Extraction was 
performed using a modified version of the CHARMS 
checklist for prognostic factors (CHARMS-PF).17 18 A 
third investigator (WC) verified all extracted data and 
calculated unadjusted odds ratios from counts.
Two reviewers (SMF and AT) independently assessed 
the risk of bias for included studies, using the QUIPS 
(quality in prognosis studies) tool.20 Disagreements 
were resolved through discussion. As our protocol 
indicates, we had initially intended to use a different 
scale for quality review, but QUIPS is recommended 
for risk of bias assessment in reviews of prognostic 
factors.17 This tool includes six potential domains 
for bias and applicability of the research question: 
study participation, study attrition, prognostic factor 
measurement, outcome measurement, adjustment for 
other prognostic factors, and statistical analysis and 
reporting.
Data synthesis
Many of the included studies of in-hospital cardiac 
arrest were extracted from large databases, including 
the American Heart Association National Registry 
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of Cardiopulmonary Resuscitation (NRCPR; later re-
named the Get With The Guidelines (GWTG) registry), 
the United Kingdom National Cardiac Arrest Audit 
(NCAA), and the Swedish Cardiac Arrest Registry 
(SCAR). For registry or large databases, we included 
the report with the largest number of patients for each 
prognostic factor. We evaluated the associated websites 
of these databases and searched through all of their 
published studies. Primary, unpublished unadjusted 
and adjusted odds ratios were obtained directly from 
the NCAA database (April 2011-March 2018) by the 
principal investigators (KMR, DAH, and JPN), and the 
data they provided exceeds the number of patients in 
any of the published NCAA reports.21-23
For the primary analysis, we present meta-analyses 
of adjusted odds ratios. All included studies in this 
primary analysis had to consider the effect of age, 
initial rhythm, or cause of arrest in their analyses. 
These variables are known to be associated with 
outcome after in-hospital cardiac arrest.1 2 We included 
meta-analyses of unadjusted values as secondary 
analyses. Odds ratio estimates and the corresponding 
confidence intervals were analysed by applying the 
DerSimonian-Laird random effects model24 using 
Review Manager (version 5.3; Copenhagen, Denmark). 
We assessed heterogeneity using the I2 statistic, the 
χ2 test for homogeneity, and visual inspection of the 
forest plots.
Two investigators (BR and GHG) evaluated overall 
certainty in pooled estimates using the GRADE (grading 
of recommendations assessment, development, and 
evaluation) approach.25 These estimates were cate-
gorised into one of four levels of certainty: high, 
moderate, low, or very low. In accordance with GRADE 
guidance for prognostic studies, cohort data start as 
high certainty evidence.25 A GRADE evidence profile 
was created using the guideline development tool 
(gradepro.org).
Patient and public involvement
After article completion, and at the suggestion of 
peer reviewers, we sought out patient representatives 
through our institution’s patient relations department. 
Patient representatives were confidentially provided 
with a copy of the article and asked to provide written 
comments on the relevance of the work, the potential 
impact of the work on their own decision making, any 
perceived shortcomings of the work, and suggestions 
for future research.
results
search results
Our search identified 10 356 citations (fig 1) and 
after removing duplicates we screened 7172 studies, 
including 83 for full text review. We included 23 
studies26-47 in our primary meta-analysis of adjusted 
results, including unpublished results from 90 276 
patients recorded on the NCAA database. Three studies 
used the NRCPR/GWTG database,29 42 44 and two 
used the SCAR database.26 43 The secondary analysis 
included an additional 30 studies.48-77
study characteristics
Table 1 presents characteristics of studies included in 
the primary analysis. Supplemental table 2 displays 
CHARMS-PF checklist detailed characteristics of each 
study, and supplemental table 3 shows consistency 
between the included studies and the CHARMS-PF 
checklist requirements. Of the 23 studies included 
in the primary analysis, 12 (52.2%) were from 
North America, and six (26.1%) were from Europe. 
All included studies used observational designs, 
and 13 (56.5%) used retrospective cohort designs. 
Thirteen (56.5%) were multicentre studies (table 1). 
Supplemental table 6 presents prognostic factors 
included in the adjustment analyses of each study.
risk of bias and quality assessment
Supplemental table 7 displays quality assessments 
performed using the QUIPS tool. Most of the included 
studies were deemed to be at low risk of bias for all 
QUIPS domains. No studies were rated as high risk of 
bias in any QUIPS domain. We judged five studies to 
have moderate risk of bias in study participation, study 
attrition, or statistical reporting.21 27 30 33 64
results of synthesis
Table 2 presents pooled adjusted odds ratios and 95% 
confidence intervals for the primary analysis, and 
GRADE level of certainty. Supplemental tables 8-9 
show GRADE evidence profiles.
Primary analyses: pre-arrest factors
We evaluated the association between patient 
demographics and survival from in-hospital car-
diac arrest. Figure 2 and figure 3 present forest 
plots.26 30 32 34 35 38-41 43 45 46 Male sex was associated 
with lower odds of survival (pooled odds ratio 0.84, 
95% confidence interval 0.73 to 0.95, moderate 
certainty). We assessed the impact of age at two 
different thresholds: age 60 and older had a pooled 
odds ratio of 0.50 (0.40 to 0.62, low certainty); age 70 
and older had a pooled odds ratio of 0.42 (0.18 to 0.99, 
low certainty).
A history of malignancy was associated with a pooled 
odds ratio of 0.57 (95% confidence interval 0.45 to 
0.71, high certainty) for survival from in-hospital 
cardiac arrest, and chronic kidney disease had a 
pooled odds ratio of 0.56 (0.40 to 0.78, high certainty). 
Single studies reported associations with congestive 
heart failure (0.62, 0.56 to 0.68, moderate certainty),38 
chronic obstructive pulmonary disease (0.65, 0.58 to 
0.72, moderate certainty),38 and diabetes mellitus 
(0.53, 0.34 to 0.83, moderate certainty).46 A diagnosis 
of acute coronary syndrome had a pooled odds ratio of 
0.70 (0.28 to 1.78, low certainty).
Primary analyses: intra-arrest factors
We investigated the association between intra-
arrest factors and survival from in-hospital cardiac 
arrest. Figure 4 and figure 5 present forest plots.28-47 
Witnessed in-hospital cardiac arrest had a pooled odds 
ratio of 2.71 (95% confidence interval 2.17 to 3.38, 
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high certainty). Arrests that took place in monitored 
settings (patients on telemetry) had a pooled odds 
ratio of 2.23 (1.41 to 3.52, high certainty). In-
hospital cardiac arrest that took place during daytime 
hours (defined as time periods when hospitals were 
fully staffed, which varied among studies) had an 
associated pooled odds ratio of 1.41 (1.20 to 1.66, 
high certainty). Initial rhythm was categorised as 
either shockable (ventricular fibrillation or pulseless 
ventricular tachycardia) or non-shockable (pulseless 
electrical activity or asystole). An initial shockable 
rhythm during in-hospital cardiac arrest was asso-
ciated with a pooled odds ratio of 5.28 (3.78 to 7.39, 
high certainty). We evaluated the prognostic impact 
of each rhythm (supplemental figs 14-17), which 
showed increased associated odds of survival among 
patients with any initial shockable rhythm. Tracheal 
intubation during in-hospital cardiac arrest was 
associated with a pooled odds ratio of 0.54 (0.42 to 
0.70, moderate certainty). Duration of resuscitation 
(that is, time from arrest to return of spontaneous 
circulation) of at least 15 minutes had a pooled odds 
ratio of 0.12 (0.07 to 0.19, high certainty).
secondary analyses
The supplemental material presents results of the 
secondary analyses. Supplemental table 10 shows 
CHARMS-PF checklist detailed characteristics of studies 
with only unadjusted results, and supplemental table 
11 shows pooled unadjusted results. Supplemental 
figs 2-20 show forest plots that compare adjusted and 
unadjusted meta-analyses of pre-arrest and intra-
arrest prognostic factors. Importantly, the direction of 
effect for all unadjusted analyses is in agreement with 
the primary adjusted analyses.
table 1 | characteristics of the 23 studies included in the 
primary analysis
Description no of studies (%)
continent of study
North America 12 (52.2)
Europe 6 (26.1)
Asia 4 (17.4)
Australia 1 (4.3)
year of publication
1990–94 2 (8.7)
1995–99 2 (8.7)
2000–04 5 (21.7)
2005–09 2 (8.7)
2010–14 6 (26.1)
2015–19 6 (26.1)
study design
Prospective cohort 10 (43.5)
Retrospective cohort 13 (56.5)
sites
Single centre 10 (43.5)
Multicentre 13 (56.5)
Excluded
Wrong outcome
Wrong population
Duplicate
13
7
10
Records identified through database search, inception to February 2019
Duplicates removed
Articles screened
Studies included in systematic review analysis
10 356
Studies included in secondary unadjusted
quantitative synthesis/meta-analysis
Studies included in primary adjusted
quantitative synthesis/meta-analysis
3184
Articles excluded by title
and abstract screening
7089
7172
Articles selected for full text review
83
30
53
5323
Fig 1 | Flowchart summarising evidence search and study selection
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discussion
We conducted a systematic review and meta-analysis 
to evaluate the association of pre-arrest and intra-
arrest factors with survival after in-hospital cardiac 
arrest. Pre-arrest factors associated with reduced 
survival include male sex, increasing age, active 
malignancy, and chronic kidney disease. Among 
intra-arrest factors, we found that witnessed arrest, 
monitored setting, arrest during daytime hours, and 
shockable rhythm were associated with increased 
survival, while tracheal intubation during arrest and 
prolonged resuscitation were associated with reduced 
survival. These findings provide evidence of the 
association between important prognostic factors and 
odds of survival after in-hospital cardiac arrest. While 
clinicians have previously extrapolated data from out-
of-hospital cardiac arrest to patients with in-hospital 
cardiac arrest,1 this study evaluated the in-hospital 
cardiac arrest population. The study identified risk 
factors that healthcare providers can consider when 
discussing expected prognosis with patients and 
making clinical decisions. Our results could be used 
to guide future large observational studies to derive a 
clinical prediction instrument for practical application. 
However, clinicians should exercise caution when 
using these results to make clinical decisions about 
starting or stopping resuscitation after in-hospital 
cardiac arrest. Nevertheless, even in the absence of an 
existing decision model, identification of risk factors 
that are associated with a poor prognosis after in-
hospital cardiac arrest will probably have value for 
clinicians in discussions about goals of care and when 
to stop resuscitation.
strengths and limitations of study
Our study involved a comprehensive search and 
included studies with an overall low risk of bias. We 
followed recent recommendations for meta-analysis of 
prognostic studies,17 evaluated several pre-arrest and 
intra-arrest prognostic factors for in-hospital cardiac 
arrest, and used GRADE guidelines to contextualise our 
findings based on overall certainty in estimates. Most of 
the estimates were based on moderate or high certainty 
evidence. Notably, we were able to include previously 
unpublished results from the NCAA database, and 
to analyse these data with published work from the 
NRCPC/GWTG, SCAR, and other databases to provide 
reliable estimates of prognostic factor association.
This review has some limitations. Firstly, our meta-
analysis included only observational studies, and 
therefore provides associations between individual 
prognostic factors and survival from in-hospital 
cardiac arrest. Given the limitations of the literature, 
we were unable to assess how the combination of these 
factors might be used to influence clinical decision 
making. Therefore, clinicians should be cautious when 
combining these findings to make clinical decisions 
about starting or stopping resuscitation. Our results 
could be used to guide future large observational 
studies to derive a clinical prediction instrument for 
practical application. However, even in the absence of 
a decision model that could be used for accurate risk 
stratification, identification of risk factors associated 
with poor prognosis could be useful for clinicians 
when discussing goals of care with patients, and when 
making clinical decisions about stopping resuscitation 
after in-hospital cardiac arrest. Our study should be 
considered in that context.
Secondly, we evaluated short term survival as 
our primary outcome because this was the outcome 
most commonly reported in the literature.3 However, 
associations between prognostic factors and neurol-
ogical outcome at discharge or long term survival are 
unknown and potentially could be more important to 
patients and caregivers. While neurological outcome 
was evaluated in some included studies, different scales 
were used, and so meta-analysis was not possible.
Thirdly, many of the factors we evaluated (namely 
age, sex, and comorbidities) are non-modifiable, 
but understanding their impact is valuable. It is 
important to emphasise the non-modifiable nature of 
these prognostic factors to patients when discussing 
advanced directives that relate to cardiopulmonary 
resuscitation after in-hospital cardiac arrest.
Finally, our study is limited by statistical and clinical 
heterogeneity. Statistical heterogeneity (assessed by 
I2) was markedly high in meta-analyses of several 
prognostic factors. While high heterogeneity suggests 
that we cannot be certain about the magnitude of 
effect size, the direction of effect size was clear for 
each factor, and visual inspection of forest plots did 
table 2 | Pre-arrest and intra-arrest prognostic factors and associated odds of survival 
after in-hospital cardiac arrest
Prognostic factors
model adjusted data
studies Or (95% ci) P* i2 (%) graDe certainty†
Pre-arrest factors
Demographics:
 Male sex 7 0.84 (0.73 to 0.95) 0.007 66 Moderate
 Age ≥60 3 0.50 (0.40 to 0.62) <0.001 50 Low
 Age ≥70 2 0.42 (0.18 to 0.99) 0.050 69 Low
Comorbidities at admission:
 Active malignancy 4 0.57 (0.45 to 0.71) <0.001 71 High
 Congestive heart failure 1 0.62 (0.56 to 0.68) <0.001 NA Moderate
 Chronic kidney disease 5 0.56 (0.40 to 0.78) 0.001 92 High
 COPD 1 0.65 (0.58 to 0.72) <0.001 NA Moderate
 Diabetes mellitus 1 0.53 (0.34 to 0.83) 0.005 NA Moderate
Admission diagnosis:
 Acute coronary syndrome 2 0.70 (0.28 to 1.78) 0.460 99 Low
 Sepsis 1 0.80 (0.70 to 0.91) 0.001 NA Moderate
intra-arrest factors
Witnessed arrest 4 2.71 (2.17 to 3.38) <0.001 68 High
Monitored patient 6 2.23 (1.41 to 3.52) <0.001 97 High
Arrest during daytime hours 5 1.41 (1.20 to 1.66) <0.001 94 High
Ventricular tachycardia 4 3.76 (2.95 to 4.78) <0.001 85 High
Ventricular fibrillation 4 3.68 (2.68 to 5.05) <0.001 94 High
Asystole 4 0.42 (0.32 to 0.56) <0.001 12 High
Pulseless electrical activity 2 0.59 (0.27 to 1.27) 0.180 77 High
Shockable rhythm 12 5.28 (3.78 to 7.39) <0.001 96 High
Intubation during arrest 5 0.54 (0.42 to 0.70) <0.001 73 Moderate
Resuscitation duration ≥15 min 2 0.12 (0.07 to 0.19) <0.001 27 High
COPD=chronic obstructive pulmonary disease; GRADE=grading of recommendations, assessment, development, 
and evaluation; NA=not applicable; OR=odds ratio.
*P values obtained from the test for overall effect.
†GRADE certainty of estimates in studies of prognosis, as described by Iorio and colleagues.25
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not reveal any important inconsistencies among 
included studies. Reliance upon the I2 statistic alone 
for quantifying the magnitude of heterogeneity in 
meta-analyses is problematic.78 In our study, the high 
I2 values were caused by a combination of several 
large national registry studies with small variability 
of effect estimates and smaller studies with larger 
variability. For this reason, the GRADE approach 
assesses statistical heterogeneity using a combination 
of factors, including I2, but also overlap of point 
Male sex
  Marwick 1991
  Brindley 2002
  Skrifvars 2007
  Shao 2016
  Chen 2016
  Al-Dury 2017* 
  UK NCAA 2018
Total (95% CI)
Test for heterogeneity: τ2=0.01; χ2=17.72,
  df=6, P=0.007; I2=66%
Test for overall effect: Z=2.68, P=0.007
Age
  ≥60
    Marwick 1991
    Shao 2016
    UK NCAA 2018
Subtotal (95% CI)
Test for heterogeneity: τ2=0.02; χ2=3.97,
  df=2, P=0.14; I2=50%
Test for overall effect: Z=6.21, P<0.001
  ≥70
    de Vos 1999
    Li 2018
Subtotal (95% CI)
Test for heterogeneity: τ2=0.28; χ2=3.22,
  df=1, P=0.07; I2=69%
Test for overall effect: Z=1.97, P=0.05
History of malignancy
  Skrifvars 2007
  Larkin 2010
  Ohlsson 2014
  Hessulf 2018*
Total (95% CI)
Test for heterogeneity: τ2=0.03; χ2=10.35,
  df=3, P=0.02; I2=71%
Test for overall effect: Z=4.96, P<0.001
History of congestive heart failure
  Hessulf 2018*
Total (95% CI)
Test for heterogeneity: Not applicable
Test for overall effect: Z=9.75, P<0.001
0.87 (0.40 to 1.90)
1.25 (0.48 to 3.29)
0.85 (0.60 to 1.20)
0.60 (0.45 to 0.80)
0.33 (0.16 to 0.66)
0.90 (0.83 to 0.99)
0.93 (0.89 to 0.97)
0.84 (0.73 to 0.95)
0.58 (0.27 to 1.25)
0.60 (0.45 to 0.80)
0.45 (0.43 to 0.47)
0.50 (0.40 to 0.62)
0.60 (0.40 to 0.90)
0.24 (0.10 to 0.60)
0.42 (0.18 to 0.99)
0.63 (0.36 to 1.11)
0.52 (0.45 to 0.58)
0.07 (0.01 to 0.54)
0.64 (0.57 to 0.72)
0.57 (0.45 to 0.71)
0.62 (0.56 to 0.68)
0.62 (0.56 to 0.68)
0.01 0.1 101 100
Study or
subgroup
Odds ratio (IV,
random, 95% CI)
Odds ratio (IV,
random, 95% CI)
-0.14
0.22
-0.16
-0.51
-1.11
-0.10
-0.07
-0.55
-0.51
-0.79
-0.51
-1.41
-0.46
-0.66
-2.63
-0.45
-0.48
Log
(odds ratio)
0.40
0.49
0.18
0.15
0.36
0.05
0.02
0.39
0.15
0.02
0.21
0.46
0.29
0.06
1.03
0.06
0.05
Standard
error
2.6
1.8
10.5
13.4
3.2
32.1
36.4
100.0
7.1
30.3
62.6
100.0
60.2
39.8
100.0
11.9
43.0
1.2
43.9
100.0
100.0
100.0
Weight
(%)
Fig 2 | Forest plots showing pre-arrest factors and associated odds of survival after in-hospital cardiac arrest. Factors 
shown are male sex, age, history of malignancy and congestive heart failure. *30 day mortality
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estimates and overlap of 95% confidence intervals.79 
After we evaluated all these measures of statistical 
heterogeneity, we felt it was appropriate to present the 
meta-analyses despite the high I2 values.
There is also clinical heterogeneity among studies 
with regard to some of the prognostic factors (for 
example, “monitoring” was referred to as continuous 
telemetry in some studies, while in others it included 
telemetry in addition to pulse oximetry). However, it 
is more likely that unknown confounders could have 
influenced the point estimates for individual studies. 
Furthermore, the clinical relevance of this heterogeneity 
is unknown. For example, the difference between 
telemetry alone versus telemetry and pulse oximetry 
might not be shown to be clinically significant. These 
sources of heterogeneity should be taken into account 
when the study results are evaluated.
Patient and public involvement
The patients involved in reviewing this study indicated 
that the study was of great importance to them and that 
identifying prognostic factors associated with outcome 
from in-hospital cardiac arrest was directly relevant to 
their care. All patients stated that, before reviewing the 
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Fig 3 | Forest plots showing pre-arrest factors and associated odds of survival after in-hospital cardiac arrest. Factors 
shown are history of chronic kidney disease, chronic obstructive pulmonary disease, and diabetes mellitus, and 
diagnosis of acute coronary syndrome and sepsis. *30 day mortality
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study, they had minimal knowledge of outcomes after 
in-hospital cardiac arrest, and were surprised to learn 
that overall outcomes were poor. They stated that the 
findings of this study allowed them to contextualise the 
likelihood of survival after in-hospital cardiac arrest, 
and that they would consider these results in their 
own decisions about cardiopulmonary resuscitation. 
One patient stated that neurological outcome was 
of particular importance, and that future research 
should prioritise neurological outcome as the primary 
outcome after in-hospital cardiac arrest.
comparison with other studies
While pre-arrest factors are typically patient specific 
and non-modifiable, they show important associations 
that could help when considering expected prognosis 
and risk stratification. We found moderate certainty 
evidence that male sex was associated with reduced 
odds of survival after in-hospital cardiac arrest. 
Existing literature on out-of-hospital cardiac arrest 
has investigated the association between patient sex 
and survival, and found improved survival among 
female patients80; however the explanation for this 
finding is unclear. Female patients might benefit 
from specific hormones (namely oestrogen) and the 
effect of these hormones on their cardiovascular risk 
profile.81 82 Coronary occlusion in women is associated 
with stronger vagal activation, and therefore reduced 
potential for dysrhythmic events and decreased 
oxygen consumption.83 Our study suggests that this 
difference between sexes for out-of-hospital cardiac 
arrest extends to in-hospital cardiac arrest, but the 
underlying mechanisms remain unclear.
We found that increasing age and prevalence 
of certain comorbidities (malignancy and chronic 
kidney disease) were associated with reduced odds of 
survival after in-hospital cardiac arrest. Hirlekar and 
colleagues showed the association between increasing 
age and mortality from in-hospital cardiac arrest in the 
SCAR database.84 In addition to the higher prevalence 
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Fig 4 | Forest plots showing intra-arrest factors and associated odds of survival after in-hospital cardiac arrest. Factors 
shown are witnessed arrest, monitored patient, and arrest during daytime hours. *30 day mortality
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of comorbidities in this population, older patients 
undergo less aggressive intervention, and survival 
from in-hospital cardiac arrest appears to decrease in 
a dose-response manner.85 We also found that patients 
with active cancer had lower associated survival from 
in-hospital cardiac arrest. The GWTG registry found 
that approximately 14% of patients in their cohort 
had advanced cancer, and that survival was markedly 
lower in this population even after taking into account 
resuscitation performance and patient directed limits 
in care.86 Increasing age and comorbidity burden are 
related to frailty, which describes a state of physiological 
decline and vulnerability.87 Future research should 
aim to investigate the association between frailty 
and outcomes after in-hospital cardiac arrest to help 
clinicians make a more accurate prognosis for patients 
admitted to hospital.88
While all of these pre-arrest factors are non-
modifiable, discussing them with patients could 
be valuable when considering the inclusion of 
cardiopulmonary resuscitation in goals of care. Non-
modifiable risk factors are particularly important 
because providing preventative care before in-hospital 
cardiac arrest or critical care after cardiac arrest will 
probably not alter patient outcome.89 90 Therefore, 
clinicians can talk with patients about these individual 
prognostic factors and poor survival after in-hospital 
cardiac arrest, even in the absence of a clinical decision 
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Fig 5 | Forest plots showing intra-arrest factors and associated odds of survival after in-hospital cardiac arrest. Factors 
shown are initial shockable rhythm, intubation during resuscitation, and duration of resuscitation longer than 15 
minutes. *30 day mortality
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model. Patients often have a poor understanding of 
outcome after in-hospital cardiac arrest, and this can 
be influenced by popular media.11 However, patients 
(particularly older patients) have found it helpful 
when clinicians provide statistics associated with 
poor survival after in-hospital cardiac arrest; when 
presented with such data, patients are more likely to 
decide against cardiopulmonary resuscitation.91 This 
view was also prevalent in the feedback provided 
by patients who reviewed our study, even though 
clinicians might not be surprised by our results. 
Therefore, our findings about pre-arrest prognostic 
factors could be helpful when clinicians discuss goals 
of care with patients.
We investigated intra-arrest factors to further 
our understanding about variables that influence 
prognosis after in-hospital cardiac arrest. We found 
high certainty evidence that patients who had in-
hospital cardiac arrest in a monitored setting (that is, 
with telemetry) had increased odds of survival. This is 
not only because of immediate recognition, but also 
potentially because patients on continuous telemetry 
are more likely to have advanced haemodynamic 
monitoring devices in place.3 Witnessed arrest was also 
associated with improved survival after in-hospital 
cardiac arrest compared with unwitnessed arrest, also 
based on high certainty evidence. This finding has 
been consistently reported in the literature related to 
out-of-hospital cardiac arrest,92 and probably reflects 
reduced latency to cardiopulmonary resuscitation. 
Interestingly, we also found that in-hospital cardiac 
arrest during daytime hours was associated with 
improved survival. Hospital staffing (physicians, 
nurses, and allied health workers) is reduced at night 
time and during weekends, and these time periods 
have been associated with increased mortality.93 94
Other important intra-arrest variables were found 
to be associated with survival. Unsurprisingly, we 
found high certainty evidence that initial rhythm was 
associated with outcome after in-hospital cardiac 
arrest. Shockable rhythms (ventricular fibrillation 
or ventricular tachycardia) were associated with 
higher odds of survival because they are more likely 
to accompany a primary cardiac cause, and because 
of the effectiveness of early defibrillation. In the out-
of-hospital cardiac arrest literature, survival from 
a shockable rhythm greatly exceeds survival after 
pulseless electrical activity or asystole75 95; our results 
for in-hospital cardiac arrest also show this trend. We 
found that prolonged duration of resuscitation (≥15 
minutes) was associated with reduced survival after in-
hospital cardiac arrest. As the duration of resuscitation 
increases, the likelihood of response to cardiac arrest 
interventions decreases, and the prolonged ischaemic 
time will probably result in irreversible organ 
dysfunction, even if return of spontaneous circulation 
is eventually achieved.2
Finally, we found that tracheal intubation during 
in-hospital cardiac arrest was associated with lower 
odds of survival, although this finding was based 
on moderate certainty evidence. This was the only 
potentially modifiable prognostic factor that was found. 
This association might be because of “resuscitation 
time bias,” because prolonged resuscitation could be 
associated with an increased number of interventions 
and worse outcome.96 However, this same finding was 
reported in a large cohort study that controlled for 
duration of resuscitation.48 Additionally, two recent 
randomised trials in patients with out-of-hospital 
cardiac arrest found that insertion of supraglottic 
airway devices resulted in at least comparable, if not 
superior, survival and neurological outcome as tracheal 
intubation.97 98 Future randomised trials on tracheal 
intubation during in-hospital cardiac arrest might 
provide more data on the optimal airway management 
strategy during in-hospital cardiac arrest.
conclusions and policy implications
We evaluated pre-arrest and intra-arrest factors 
associated with survival after in-hospital cardiac 
arrest. Of the pre-arrest factors, male sex, increasing 
age, active malignancy, and chronic kidney disease 
were associated with reduced survival. Of the intra-
arrest factors, witnessed arrest, monitored setting, 
cardiac arrest during daytime hours, and shockable 
rhythm were associated with increased survival, while 
tracheal intubation and prolonged resuscitation were 
associated with reduced survival. These findings 
provide evidence of associations between important 
prognostic factors and survival after in-hospital 
cardiac arrest.
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